在不可切割的头癌患者的生存和预后因素
Natsuki Oishi1,2, Sara Orozco-Núñez1, José Ramón Alba-García1,2
1ENT Department, General University Hospital of Valencia, 46014 Valencia, Spain.
Journal of clinical medicine
|August 14, 2025
概括
患有不可切除的头角状细胞癌侵入重要结构的患者的平均整体存活时间为16个月. 预后不佳与瘤复发和人类乳头瘤病毒 (HPV) 阴性状态有关.
科学领域:
- 在瘤学瘤学.
- 头部和部手术 头部和部手术
- 癌症研究 癌症研究
背景情况:
- 不切除的头部和部状细胞癌 (HNSCC) 侵入重要结构在文献中表现不足.
- 了解生存结果对于治疗计划和患者预期管理至关重要.
研究的目的:
- 描述涉及重要结构的不可切除HNSCC患者的平均整体存活期 (OS).
- 根据呈现类型,在子组内确定临床特征和预后指标.
主要方法:
- 这是一项单一队列观察后续研究,对39名晚期HNSCC.患者进行了观察后续研究.
- 由于侵入了重要解剖结构,患者被认为无法接受手术切除.
- 分析了整体存活率,根据表现和临床特征进行分组评估.
主要成果:
- 在24个月的随访期间,无法切除的HNSCC患者的中位数OS为16.09个月.
- 在被纳入的患者中,56.4% (平均年龄为66.87岁) 在研究结束时死亡.
- 在人类乳头瘤病毒 (HPV) 阳性和阴性患者之间,以及最初和复发性瘤之间,观察到生存率的统计学上显著差异.
结论:
- 侵入重要结构 (头骨底部,动脉,前脊椎空间) 显著降低了HNSCC患者的生存率.
- 瘤复发和HPV阴性状态是不可切除的HNSCC中预后不佳的重要指标.
- 这项研究为不可切除的HNSCC与生命结构入侵提供了有价值的预后证据.
相关概念视频
01:21Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K